The Traderszone Network

24 September, 2014 by The TZ Newswire Staff Comments Off on Sales of US new homes soar in August

Sales of US new homes soar in August

WASHINGTON (AP) — U.S. sales of new homes surged in August, led by a wave of buying in the West and Northeast.

24 September, 2014 by The TZ Newswire Staff Comments Off on Mortgage-dependent home buyers aren’t moving

Mortgage-dependent home buyers aren’t moving

After a surge in refinances in the previous week, the volume of mortgage applications continued to slide as interest rates rose to their highest level in several months.

24 September, 2014 by The TZ Newswire Staff Comments Off on Bitcoin: History repeating as chart suggests a breakout is coming

Bitcoin: History repeating as chart suggests a breakout is coming

Is bitcoin poised for a breakout? Jeff Macke and Josh Brown discuss.

24 September, 2014 by The TZ Newswire Staff Comments Off on Oil company rewrites its history, may aid founder’s divorce case

Oil company rewrites its history, may aid founder’s divorce case

Oil driller Continental Resources Inc has been revising its corporate history in ways that diminish the publicly traded company’s accomplishments under CEO Harold Hamm, part of a legal strategy that might help Hamm avoid the largest divorce award in U.S.

24 September, 2014 by The TZ Newswire Staff Comments Off on Stocks Rally To Session Highs; Celgene Leads Biotech Rally

Stocks Rally To Session Highs; Celgene Leads Biotech Rally

Major averages rallied off lows and were near session highs more than two hours into Wednesday’s session. The Nasdaq led the way, up 0.6%, after touching its 50-day moving average. The Dow Jones industrial average and S&P 500 added 0.5% each. NYSE volume was tracking higher than Tuesday’s levels. Nasdaq volume was lower. In economic news, August new-home sales came in at 504,000, well above expectations.

read more

24 September, 2014 by The TZ Newswire Staff Comments Off on The Wall Street Journal: Inovio, GeneOne to move Ebola vaccine to human trials

The Wall Street Journal: Inovio, GeneOne to move Ebola vaccine to human trials

Companies plan to start Phase I clinical trial in first half of 2015.
read more

24 September, 2014 by The TZ Newswire Staff Comments Off on The Wall Street Journal: Tax changes dim appeal, but AbbVie-Shire deal still seems likely

The Wall Street Journal: Tax changes dim appeal, but AbbVie-Shire deal still seems likely

AbbVie’s proposed buyout of Ireland-based Shire still seems likely to go through, although new government rules concerning tax-inversion deals have made the deal less appealing to shareholders.
read more